Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of Different Doses of Magnesium as a Protective Agent in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer

NCT05586009 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05586009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05586009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of Different Doses of Magnesium as a Protective Agent in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer
Lead sponsor
Tanta University
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2022
Completion date
March 30, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cisplatin adverse reaction